NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
InspireMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.44−0.02 (-3.34%)
Close on Oct 19, 2026
- Market cap
- $37.25M
- P/E (TTM)
- –
- Dividend yield
- –
InspireMD, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries [Member] | $1.11M | $1.31M | $1.33M | $1.14M | $658.00K | $772.00K | $1.02M | $825.00K | $961.00K | $822.00K | $1.37M | $647.00K | 62.7% | +68.8% |
| Italy | $304.00K | $354.00K | $354.00K | $293.00K | $324.00K | $262.00K | $358.00K | $306.00K | $264.00K | $295.00K | $263.00K | $328.00K | 17.2% | -6.2% |
| Germany | $265.00K | $255.00K | $251.00K | $380.00K | $360.00K | $242.00K | $71.00K | $306.00K | $307.00K | $242.00K | $197.00K | $209.00K | 15.0% | -26.4% |
| Poland | $262.00K | $301.00K | $350.00K | $211.00K | $249.00K | $226.00K | $160.00K | $176.00K | $207.00K | $152.00K | – | $122.00K | 14.8% | +5.2% |
| Argentina | $180.00K | – | – | – | $160.00K | – | – | – | – | – | – | – | 10.2% | +12.5% |
| U.S. [Member] | -$351.00K | $1.18M | $866.00K | $497.00K | $27.00K | $27.00K | $3.00K | $7.00K | – | – | – | – | -19.8% | -1400.0% |
| Russia | – | – | – | – | – | – | $338.00K | $190.00K | – | – | $255.00K | $250.00K | – | – |
From the segment and revenue-disaggregation notes of InspireMD's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.